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Well-known as one of the main sources of cerebrospinal fluid (CSF), the choroid plexuses
have been, and still remain, a relatively understudied tissue in neuroscience. The choroid
plexus and CSF (along with the blood-brain barrier proper) are recognized to provide
a robust protective effort for the brain: a physical barrier to impede entrance of toxic
metabolites to the brain; a “biochemical” barrier that facilitates removal of moieties
that circumvent this physical barrier; and buoyant physical protection by CSF itself. In
addition, the choroid plexus-CSF system has been shown to be integral for normal brain
development, central nervous system (CNS) homeostasis, and repair after disease and
trauma. It has been suggested to provide a stem-cell like repository for neuronal and
astrocyte glial cell progenitors. By far, the most widely recognized choroid plexus role
is as the site of the blood-CSF barrier, controller of the internal CNS microenvironment.
Mechanisms involved combine structural diffusion restraint from tight junctions between
plexus epithelial cells (physical barrier) and specific exchange mechanisms across the
interface (enzymatic barrier). The current hypothesis states that early in development this
interface is functional and more specific than in the adult, with differences historically
termed as “immaturity” actually correctly reflecting developmental specialization. The
advanced knowledge of the choroid plexus-CSF system proves itself imperative to
understand a range of neurological diseases, from those caused by plexus or CSF
drainage dysfunction (e.g., hydrocephalus) to more complicated late-stage diseases (e.g.,
Alzheimer’s) and failure of CNS regeneration. This review will focus on choroid plexus
development, outlining how early specializations may be exploited clinically.
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INTRODUCTION
The first description of the lateral ventricular choroid plexuses is
credited to Herophilos (c. 335–280 B.C.) by Galen of Pergamon
(see Liddelow, 2011)—he named the structure the “chorioid
mennix,” “chorioid” being taken from the outer vascular plexus
of the fetus. Two centuries years later, Rufus of Ephesus (c. 100
A.D.) suggested the term “chorioid tunic” be used to describe
both the ependyma and choroid plexus. A century and a half
of silence followed which was broken when Vesalius reported
the gross anatomy of the choroid plexus of the lateral ventricles
in his De humani corporis fabrica libri septem (On the fabric
of the human body. Book 7: The brain - Vesalius, 1543) before
Willis (1664) described the choroid plexus of the fourth ven-
tricle and hypothesized the choroid plexus contained gland-like
structures which produced the fluid found in the ventricles. The
entire extent of the choroid plexuses was known when Ridley
(1695) described the choroid plexus of the third ventricle. After
these ancient and distant times, there was a resurgence of descrip-
tions of choroid plexus pathologies in the 1910–1930s (Dandy,
1918; Somerford, 1933; Cohen and Davies, 1939 among others)
Abbreviations: CNS, central nervous system; CSF, cerebrospinal fluid; SLC, solute
carrier
and more traditional investigative descriptions from the 1960s
onwards, first on micrographs about the structure and morpho-
logical changes in the shape and distribution of plexus epithelial
cells and vasculature (Tennyson and Pappas, 1964; Cancilla et al.,
1966; Netsky and Shuangshoti, 1970; Stastný and Rychter, 1976;
Sturrock, 1979; Keep and Jones, 1990; Dziegielewska et al., 2001;
Liddelow et al., 2010) and later on alterations in the perceived
function of the plexus by investigations of cerebrospinal fluid
(CSF) (Evans et al., 1974; Johanson et al., 1976; Habgood et al.,
1992; Liddelow et al., 2014). Though a wealth of information
has been gathered about early developmental origins and growth
of the choroid plexus through these means, only recently has
research moved to the application of modern technologies to
study cues involved in choroid plexus development and mat-
uration. Recent studies on plexus epithelial cell differentiation
and genetic lineage analyses along with high throughput genetic
expression datasets have provided a wide assortment of data
for further investigation. Beyond the historic descriptions of its
emergence from neuroectodermal progenitor pools, these recent
studies have put emphasis on the importance of the choroid
plexuses for normal and regulated development of the remain-
der of the brain, as well as the role this seemingly small structure
plays in normal aging and disease.
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In the mouse embryo, the choroid plexus accounts for 27%
of the total ventricular wall area (Knudsen, 1964) and in human
embryos this value is even larger (approximately 63% of the ven-
tricular surface; Voetmann, 1949), the importance of the choroid
plexus in normal brain development and function is therefore
immense. This review will spend some time discussing the molec-
ular expression of transcription factors and emergence of the
choroid plexuses during early embryogenesis, before embarking
on a discussion on disruption of normal plexus mechanisms of
action during aging and disease. Due to the excess of information
available on the telecephalic (lateral ventricular) choroid plexus,
the majority of discussions will be focussed on this plexus, how-
ever, when other structures are considered they will be listed as
such.
NORMAL DEVELOPMENT
The choroid plexuses, found in the lateral, third and fourth ven-
tricles of the brain (adjacent to the embryonic dorsal midline
in the hindbrain, diencephalon, and telencephalon, respectively)
are epithelial tissue masses highly vascularized with fenestrated
blood vessels (Figure 1). These structures constitute a transfer
interface between blood and CSF in the ventricles of the brain.
Approximately two thirds of this CSF is produced and secreted
by the choroid plexus, the remainder produced by other areas
such as the ependymal cells of the ventricular surface and those
cells lining the subarachnoid space (see Davson and Segal, 1996;
Zheng and Chodobski, 2005 for review). This fluid circulates
in the ventricular system, subarachnoid spaces and spinal canal
(for review see Davson and Segal, 1996; Saunders et al., 2000;
Zheng and Chodobski, 2005) and the plexuses are able to control
the homeostasis of its composition by regulation of movement
of essential ions and molecules into, and metabolites out of the
CSF (Kusuhara and Sugiyama, 2004; Saunders et al., 2013). The
choroid plexuses are the main structures that comprise the blood-
CSF barrier, the other contributors being the arachnoid and
arachnoid villi on the outer surface of the brain (Wright, 1978;
and for review see Davson and Segal, 1996). Together these inter-
faces provide a protective restriction barrier formed by bands of
tight junctions between adjacent cells that impede the movement
of molecules into the central nervous system (CNS). In addi-
tion to this mechanical barrier, the barrier interfaces comprise a
biochemical barrier— an additional protective mechanism that
effluxes toxic molecules and drugs taken up by cells in the blood-
CSF barrier (see Ek et al., 2010; Kratzer et al., 2013). This review
will focus on the choroid plexus over the arachnoid membrane,
however many properties are retained in both interfaces.
GROSS MORPHOLOGICAL DEVELOPMENT
As the choroid plexuses themselves do not have distinct prolif-
erative zones; there is much evidence showing (and is widely
accepted) the choroid plexus stroma has mesenchymal origins,
like meningeal cells, while the actual plexus epithelial cells are
derived from neuroepithelium. Genetic lineage analyses indicate
the plexus epithelium originates from the roof plate (Awatramani
et al., 2003; Currle et al., 2005; Hunter and Dymecki, 2007) -
a well-known signaling center in early CNS development. From
this area the migration of pre-plexus cells can be traced. The post
differentiated development of the choroid plexus cells themselves
has proved a more difficult beast to investigate. Much study using
cell division markers have shown no examples of choroid plexus
epithelial cells undergoing division to produce additional plexus
epithelium, while in contrast, many mitotic figures have been
described in the nearby neuroependyma (Zand, 1930; Kappers
et al., 1958). An aside should be noted however that there are
examples of a proliferative choroid plexus giving rise to neuronal
and glial lineage cells (Itokazu et al., 2006; Bolos et al., 2013). The
neuroependyma, originally formed by invagination of the ante-
rior end of the neural tube (Imayoshi et al., 2008), proceeds to
divide into three regions:
(1) the most lateral region gives rise to cortical neuroepithelium,
which further develop to neurons and glia of the cortex;
(2) the medial or dorsal telencephalic midline regions is split in
two, with the cortical hem being amajor source of neocortical
Cajal–Retzius cells; and
(3) the most medial region of the dorsal telencephalic midline
gives rise to choroid plexus epithelium.
Systematic studies on histogenesis of plexus epithelial cells report
it arises from an infolding of the multilayered roof plate of
the neural tube, between the paraphyseal arch and the medial
wall (Bailey, 1916; Tennyson and Pappas, 1964; Sturrock, 1979;
Thomas and Dziadek, 1993; Awatramani et al., 2003; Currle et al.,
2005; Hunter and Dymecki, 2007). In addition, it has been shown
with chick-quail chimeras (Wilting and Christ, 1989) that specific
cells destined to develop into choroid plexus are detectable up to
72 h before the structure even emerges from the neuroependy-
mal wall of the ventricles. This “pre plexus” empendyma has been
shown to envelope connective tissue and develop blood vessels,
more representative of a mature plexus, upon direct contact with
tissue derived from the mesodermal germ layer (Sarnat, 1998),
suggesting cues for plexus differentiation are indeed released by
nearby cell types in the developing CNS.
Once entering the plexus, newly differentiated cells undergo
maturation through four distinct stages; described in many dif-
ferent species with the distinct difference in marsupials that
glycogen is absent (Dziegielewska et al., 2001; Ek et al., 2003).
The four stages as described by Tennyson and Pappas (1964)
and Sturrock (1979) are as follows: Stage I (see Figure 1C): the
early epithelial cells are pseudostratified with nuclei that are cen-
trally located. Stage I plexus epithelia are widely accepted to
not contain extensive apical villi (common in the adult plexus).
Stage II: low columnar to cuboidal epithelial cell shape, with
an emerging basal connective tissue. Apical villi are still absent,
though some villi-like extensions are seen in late-stage cells.
Nuclei movemore apically in the cell. Stage III: nowwith cuboidal
epithelial cells and basally-located nuclei it is in this stage cilia
on the apical cell surface appear, along with a great increase
in complexity of the capillary network, with an accompanied
increase in the number of villi. Stage IV (see Figure 1C): in
the final stage of plexus epithelial cell development transition to
cuboidal cells is complete and the cells become slightly smaller
(approximately 10μm2 in profile), with most nuclei situated
centrally-to-basally within the cytoplasm. While additional cells
are continuously added to the choroid plexus throughout early
development and cell maturation, these newly added cells will
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FIGURE 1 | Location of choroid plexuses in the human brain. (A)
The choroid plexuses are present in the two lateral, third and fourth
ventricles (red ribbons). (B) Each of the plexuses is comprised of
fenestrated vessels, with a single layer of intimately opposed choroid
epithelial cells, joined by tight junctions—forming the blood-
cerebrospinal fluid barrier. (C) Transmission electron micrographs of
lateral ventricular choroid plexus. Stage I–the epithelial cells are
pseudostratified with centrally located nuclei. Stage II/III–low columnar
to cuboidal, basal-to-centrally located nuclei, with apical villi present
(arrows, a characteristic from stage III onwards). Stage IV–cuboidal
epithelial cells with central-to-apical nuclei and many villi (arrows). (C)
reproduced from Ek et al. (2003) Copyright ©2003 Wiley All rights
reserved. Abbreviations: BV, blood vessel; CP, choroid plexus; CPEC,
choroid plexus epithelial cell; CSF, cerebrospinal fluid; LV, lateral
ventricle; NU, nucleus; ST, stroma/basement membrane; TJ, tight
junction; 3V, third ventricle.
transition through the four stages of development outlined. A
continued proliferative effort by plexus epithelial cells has been
shown to occur even after the original spreading from the neu-
roependymal wall, though it should be noted that this division
usually gives rise to cells that are not reminiscent of plexus
epithelium. The choroid plexus epithelial cells from rats from
newborns to 8 weeks of age have been shown to function as
neural progenitor cells (which can give rise to astrocytes) how-
ever this ability decreases with age, with cells from P1 animals
twice as likely to undergo this change as those from adult (8
week) animals (Itokazu et al., 2006). It is important to note
however this proliferation only occurred after explanting to an
ectopic location - continued proliferation of the neuroepedyma
which adds additional choroid plexus epithelial cells occurs in
adult rat only at an extremely low rate (less than 0.1% of total
plexus cells, see Altman and Das, 1965; Doetsch et al., 1999;
Liddelow et al., 2010; Johansson et al., 2013). It is interesting to
note that in APP/PS1 mice that overexpress amyloid precursor
protein and express mutated presilin 1 (important in generation
of beta amyloid) there is an almost 5-fold increase in the num-
ber of newly divided cells in the choroid plexus at 1 year of age
(Bolos et al., 2013). The authors however comment that these
newly dividing cells represent proliferation of immature neurons
in the choroid plexus and not new plexus epithelial cells per-se—
suggesting the choroid plexus as an important adult stem cell
niche.
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TRANSCRIPTION FACTORS INVOLVED IN PLEXUS PATTERNING AND
DEVELOPMENT
Like all forms of early brain development, growth andmaturation
of choroid plexus is regulated by coordinated actions of multiple
signaling centers at key boundaries between nearby anatomi-
cal compartments (refer to Table 1 for a non-complete list).
Three neighboring telencephalic midline structures are situated
to perform such roles in forebrain patterning: the cortical hem,
the septum, and the thalamic eminence at the diencephalic—
telencephalic boundary. These structures all express unique com-
plements of signaling molecules. The medial-lateral patterning
of dorsal regions of the telencephalon is regulated by a large
number of transcription and secreted signaling factors. Some
secreted factors, including members of the bone morphogenic
protein (BMP) family of proteins, regulate specification of the
choroid plexus epithelium by inducing MSX1 and repressing
Table 1 | Factors involved in the development of the choroid plexus epithelial cells.
Gene/Factor Function Species References
Bmps Misexpression causes expansion of choroid plexus at the expense of cortical
neuroepithelium. Deficits cause loss of specification of plexus epithelial cells.
BMP4 gives rise to choroid plexus epithelial cells from E10.5 in mouse
Mouse Panchision et al.,
2001; Hébert et al.,
2002; Fernandes
et al., 2007;
Imayoshi et al., 2008
E(spl) Homologs of genes present in mammalian species Mouse, rat Kageyama et al.,
2007;
E2F5, foxJ1, p73 Lack of functional transcription factor causes hydrocephalus due to
dysfunction of choroid plexus, mostly dysfunctional cilia on CSF surface of
cells and AQP3 channels
Mouse, human (cells) Chen et al., 1998;





Swetloff et al., 2006
Hairy, E(spl) bHLH repressor genes regulate non-neuronal versus neuronal fate
specification in the ectoderm. Up-regulation of E(spl) represses neuronal
specification, promoting non-neuronal cell fate
Drosophila Campos-Ortega and
Jan, 1991
Hes1, Hes3, Hes5 Gives rise to choroid plexus epithelial. Knock-out mice have no lateral
ventricular choroid plexus
Mouse Imayoshi et al., 2008
Lmx1a Gives rise to choroid plexus epithelial cells, from E10.5 onwards in mouse Mouse Imayoshi et al., 2008
Msx1/2 Development of dorsal midline region Mouse Hébert et al., 2002;
Bach et al., 2003
Msx1/2 Induce Fox and Msx genes, causing regulation of specification of choroid
plexus epithelium
Mouse Xuan et al., 1995;
Furuta et al., 1997;
Porter et al., 1997;
Monuki et al., 2001
Ngn2 Gives rise to choroid plexus epithelial cells and Cajal-Retzius cells,
upregulation causes a loss of choroid plexus epithelial cells
Mouse Imayoshi et al., 2008
Notch1 Expression of activated Notch1 results in overproduction of hindbrain choroid
plexus epithelium (but not of other rhombic lip lineages)
Mouse Hunter and Dymecki,
2007
Otx2 Master regulator of choroid plexus development. Knock-out causes failure of
choroid plexus to develop
Mouse Johansson et al.,
2013
Wnt2b Gives rise to choroid plexus epithelial cells, from E10.5 onwards in mouse Mouse Imayoshi et al., 2008
A list of known transcription factors involved in the development of neuroependymal cells of the ventricular wall into choroid plexus epithelial cells. Refer to Figure 2
for the localization of these factors. This list is by no means exhaustive. Abbreviations: bLHH, basic helix-loop-helix; BMP; bone morphogenic protein; E(spl), enhancer
of split; foxJ1, forkhead box J1;Hes, hairy and enhancer of split; Lmx1a, LIM homeobox transcription factor 1α; Ngn2, neurogenin 2; Otx2, orthodenticle homeobox
2; p73, tumor protein 73; Wnt2b, wingless-type MMTV integration site family member 2B.
Frontiers in Neuroscience | Neurogenomics March 2015 | Volume 9 | Article 32 | 4
Liddelow Choroid plexus development
LHX2/FOXG1 levels (Xuan et al., 1995; Furuta et al., 1997; Porter
et al., 1997; Monuki et al., 2001; Panchision et al., 2001; Hébert
et al., 2002; Bach et al., 2003; Fernandes et al., 2007; Johansson
et al., 2013). The cortical hem is a WNT and BMP rich signal-
ing center connected to the choroid plexus on one side and the
cortical neuroepithelium on the other (Grove et al., 1998). A lack
of the constitutively active form of the receptors for BMPs results
in a massive expansion of the choroid plexus epithelium at the
expense of the cortical neuroepithelium (Panchision et al., 2001).
In contrast, inactivation of BMP receptors results in retarded
growth of the choroid plexus, specifically of the epithelial cells
(Hébert et al., 2002; Fernandes et al., 2007). One could argue
a reduction of BMP receptors on cells in the ventral surface of
the neuroepithelium close to the root of the plexus and a large
number of these receptors on the dorsal surface may aid in the
one-sided growth pattern outlined by Liddelow et al. (2010).
The fruit fly Drosophila has recently become an invaluable tool
in the rapid expansion of the molecular knowledge on the fate
specification of cells in the ectoderm. There are severalDrosophila
basic helix-loop-helix repressor genes, such as Hairy/Enhancer of
Split [E(spl)], able to regulate the non-neuronal versus neuronal
specification of cells (Campos-Ortega and Jan, 1991). When cells
adopt the neuronal fate they express Delta, which in turn acti-
vates Notch signaling in neighboring cells, in turn up-regulating
E(spl) expression, promoting non-neuronal cell fate (Campos-
Ortega and Jan, 1991). This raises the possibility these repressor
genes are involved in the formation of non-neuronal tissues in the
brain. Mammalian homologs of these genes, the Hes gene family,
have been shown to be involved in formation of non-neuronal
tissue in developing mouse brain (Imayoshi et al., 2008). In these
experiments, expression of Bmp4, Hes1, and Hes5 is seen in the
neuroepithelium directly adjacent to the choroid plexus on the
upper (dorsal) surface. This localizes the factors in the correct
position to aid in the switch to non-neuronal cell fate required for
choroid plexus development. In addition Hes1 and Hes5 expres-
sion is absent on the lower (ventral) surface of the choroid plexus
root, while Bmp4 expression is still present— possibly causing
impedance of mitosis or non-neuronal fate in this area. In addi-
tion, inactivation of the repressor genes Hes1, Hes3, and Hes5
causes up-regulation of the proneural gene neurogenin-2 (Ngn2),
prematurely depleting Bmp expressing progenitor cells causing
loss of choroid plexus epithelial cells (due to the enhanced forma-
tion of Cajal-Retzius cells; Imayoshi et al., 2008). A similar effect
is seen when bypassing the Hes genes and simply up-regulating
Ngn2 expression.
Another set of transcription factors present in choroid plexus
epithelial cells immediately after their differentiation from the
neuroependyma, E2f5, FoxJ1, and P73, when expressed in
aberrant levels cause non-obstructive hydrocephalus in mouse
(Swetloff and Ferretti, 2005). The levels of E2F5 protein in the
brain are highest in embryonic development and lower in the
adult in mouse (Dagnino et al., 1997; Persengiev et al., 1999;
Swetloff and Ferretti, 2005) which correlates well with plexus
growth patterns—which is most rapid during early develop-
ment, but reaches a plateau shortly after birth (Liddelow et al.,
2010). The amount of E2F5 protein is also increased in nuclei
of choroid plexus epithelium of both mouse and human early in
development, suggesting it may be more important for matura-
tion of plexus epithelial cells rather than for the original transition
from their neuroependymal cell beginnings (Swetloff and Ferretti,
2005). A summary of the position of these transcription factors
is outlined in Table 1 and Figure 2. The proliferative nature of
choroid plexus epithelial cells has also been shown to occur even
after the original dissemination from the neuroependymal wall
and a possible neuronal fate. After a graft of plexus epithelium
into the spinal cord of the adult rodent, plexus epithelium is able
to differentiate into astrocytes (Ide et al., 2001; Kitada et al., 2001).
Though the authors do not comment on what may have caused
the switch from epithelial cell to astrocyte, it appears likely some
local factor in the environment of the spinal cord has caused the
transformation. In addition, choroid plexus epithelial cells from
rats at a range of developmental ages from postnatal day 1 to 8
weeks have been shown to have an ability to function as neural
progenitor cells, however this ability decreases with age, with the
plexus epithelium from P1 animals twice as likely to undergo the
change than those from adult (8 week) animals (Itokazu et al.,
2006). The considerable potential for growth by the adult choroid
plexus is demonstrated by growth of the choroid plexus (almost
FIGURE 2 | Location of expression of transcription factors known to
be important in plexus development and growth. The choroid plexus
epithelial cells develop from modified neuroepithelium and are only
added to the structure from the dorsal surface. No addition of cells is
described from the ventral surface, and no transcription factors that
promote differentiation into choroid plexus epithelium have been reported
as expressed in this region. For full list of transcripts and references
refer to Table 1. CSF, cerebrospinal fluid.
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40-fold in the adult) by intrathecal infusion of fibroblast growth
factor 2 or epidermal growth factor (Itokazu et al., 2006).
More recently, Otx2 (orthodenticle homeobox 2) has been
implicated as the master regulator of choroid plexus differenti-
ation (Johansson et al., 2013). Like Emx2,Otx2 is expressed in the
dorsal roof plate and both play important roles in specification of
neuroepithelial versus choroid plexus regions (von Frowein et al.,
2006). Emx1 and Emx2 are regulators able to supress plexus cell
fate differentiation, whileOtx2 pushes cells into a plexus epithelial
lineage, the two regulators working in tandem to ensure correct
pattering early in development. Indeed, deletion of Otx2 suffi-
ciently early in development causes failure of the choroid plexus
to occur, while deletion once the plexus has developed causes
epithelial cells to enter an apoptotic pathway, though no apop-
totic cells were visualized by the authors (Johansson et al., 2013).
These data hypothesize Otx2 is absolutely required for normal
choroid plexus development; however its importance in the gen-
eral maintenance in the mature/adult choroid plexus is yet to be
ascertained. It is known however in humans the obliteration of
the lateral ventricular choroid plexus as a treatment for hydro-
cephalus results in no regeneration of the structure (Hallaert
et al., 2012; Ogiwara et al., 2014). This suggests early develop-
mental growth factor patterning cues are paramount for normal
plexus development, and the structure cannot regenerate from
already-present plexus epithelium.
FUNCTION OF CHOROID PLEXUS EPITHELIAL CELLS
The epithelial cells of the choroid plexus have many functions
important for normal embryo development. They are princi-
pally recognized as producing a large proportion of the CSF, and
acting as site of the blood-CSF barrier, a protective mechanism
that ensures the stability of the CSF milieu (Davson and Segal,
1996; Zheng and Chodobski, 2005; Saunders et al., 2008; also
see Introduction). Like other brain barriers, the choroid plexus
blood-CSF barrier is formed by presence of specialized junctions
between adjacent epithelial cells (Wolburg et al., 2001; Saunders
et al., 2008; Liebner et al., 2011). The molecular make-up of tight
junctions of the blood–CSF barrier is less well-known than those
that comprise the blood-brain barrier (Wolburg et al., 2001).
A recent study of tight junction protein expression in mouse
embryos (E15) and adult choroid plexus has shown several key
junctional genes are expressed at a higher level in embryos than
in the adults (e.g., Pcdh, Cldn5), whereas for several other genes
the reverse is the case (e.g., Igsf5, Cldn2, see Liddelow et al., 2012).
This is consistent with previous findings that the fundamental
functional basis of this barrier, namely occlusion of the paracellu-
lar diffusion pathway, is well-established from the earliest stages
of differentiation of the choroid plexuses (Bauer et al., 1993; Ek
et al., 2003, 2006). The critical function of these junctions is to
join the cells together to create a physical barrier to paracellu-
lar diffusion, allowing cells to polarize with distinct luminal and
abluminal components. The presence of these junctions between
cells of the interface between the periphery and the CNS allows
cellular transporters to be effective in controlling the distribution
of solutes on either side, and thus set up concentration gradients.
These gradients are not only important formature brain function,
but are also likely to be significant for essential features of early
brain development (cell division, migration, differentiation and
synaptogenesis). For instance, the most active transporter in the
choroid plexus appears to be theNa+/K+ ATPase pump—integral
for maintenance of the ion gradient that draws water into the
ventricles via aquaporin-1 (AQP1) channels in the plexus epithe-
lium (see below). Plexus barrier junctions are tight to molecules
as small as lanthanum ion (139 Da; Brightman and Reese, 1969)
and tracer molecules such as BED (286 Da; see Ek et al., 2003)
and larger dextrans from 30 kDa (Ek et al., 2003, 2006) up to
70 kDa (Liddelow et al., 2009)—more in line with the size of
plasma proteins. The presence of this functional barrier is an
essential prerequisite for the establishment and maintenance of
concentration gradient for ions and proteins between the blood
(basal side of the cells) and the CSF on the apical side (see Speake
and Brown, 2004). Indeed earlier permeability experiments have
already shown that when administered peripherally acidic dyes
(Ehrlich, 1885; Goldmann, 1909) or more recently biotinylated
and fluorescently-labeled dextran molecules (Ek et al., 2003) only
enter the plexus structure and do not enter the CNSmilieu. These
junctions of the plexus are present from the first emergence of
the structure from the wall of the ventricles, however as tran-
scriptome profiling of the possible molecular make-up of this
structure has only recently been completed (Marques et al., 2009;
Liddelow et al., 2012; Kratzer et al., 2013) there are no plexus-
specific knock-out animal models available to further investigate
the role of these individual molecules in dysfunctions of plexus
development and function.
At all stages of development, the plexus epithelial cells are able
to produce and secrete CSF and regulate transfer of molecules
across the blood/CSF interface, as tight junctions are present
between adjacent cells immediately following their entry from the
neuroepithelium. For lipid insoluble substances, such as proteins,
this transfer has been shown to be across choroid plexus epithe-
lial cells both in development and in the adult (Møllgård et al.,
1979; Ek et al., 2003; Johansson et al., 2006; Liddelow et al., 2009).
However, not all choroid plexus cells seem to be involved in this
process, the proportion ranges between less than 5% in the adult
to about 15% during early stages of brain development in opos-
sum (Liddelow et al., 2009) and rat (Johansson et al., 2006), to
over 40% in sheep (Balslev et al., 1997) and humans (Møllgård
and Saunders, 1977). These processes of early plexus epithelia will
be covered in more detail below.
SOLUTE CARRIERS
Transport across the blood–brain barrier and blood–CSF bar-
rier is directional, with different classes of transporters involved
in movement into (e.g., most SLC transporters) and out of
(e.g., ABC efflux pumps, see Figure 3). Additionally, there are
both active and passive transporters: active mechanisms move
solutes up their concentration gradients and require energy (ATP,
e.g., Na+/K+ ATPase), while passive mechanisms move solutes
down their concentration gradients and are energy-independent
processes. Together, these combined transporters can have a mul-
titude of effects from removal of solutes from the CSF, preventing
their entry into the brain (efflux mechanisms), initiation of ion
gradients or delivery of specific nutrients, ions and other required
molecules to the brain cells (influx mechanisms).
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FIGURE 3 | Schematic representation of transport pathways across
the blood-cerebrospinal fluid barrier. The blood-cerebrospinal fluid
(CSF) barrier is formed by tight junctions between neighboring choroid
plexus epithelial cells—halting the paracellular movement of molecules
both into, and out of, the brain. Additional chemical barriers exist to
impede movement of molecules into the central nervous system.
1–Diffusion for hydrophilic molecules through a paracellular pathway is
halted by tight junctions (TJ) between adjacent choroid plexus
epithelial cells. 2–Efflux transporters (e.g., ABC family) actively remove
specific (mostly) lipophilic solutes from cell cytoplasm and extracellular
space. Though the majority of evidence suggests a basolateral
removal of molecules to the blood space, there is some evidence
that ABCB1 (PGP) and ABCG2 (BCRP) localize to the apical
membrane of the choroid plexus (Rao et al., 1999; Gao and Meier,
2001; Gazzin et al., 2008; Niehof and Borlak, 2009; Ek et al., 2010;
Reichel et al., 2011), however their function in this position is
unknown. 3–Inward transporters (e.g., SLC family) actively transport
ions, amino acids, and other small molecules across both basolateral
and apical surfaces of plexus epithelial cells into the CSF. Without
this active transport these molecules would be unable to cross the
blood–CSF barriers as they are too hydrophilic and/or highly polarized.
4–Bi-directional transporters (e.g., OAT family). 5–Protein transporters
(e.g., SPARC for albumin) specifically target individual proteins (or
classes of protein) and transport them across the cells. 6–Vesicular
transport/endocytosis due to presence of specific receptors (e.g.,
transthyretin receptor, TTR; insulin receptor, INSR) or non-specific
mediators (e.g., vesicle-associated membrane proteins, VAMPs). 7–Bulk
water flow from blood to CSF via aquaporin transporters, specifically
AQP1 (Johansson et al., 2005).
From early in development and throughout adulthood, the
occlusion of pathways between plexus epithelial cells produce an
environment that allows for gradients to exist across the inter-
face. These ion gradients are due to the presence of transporters
on both sides of the choroid plexus epithelium and can trans-
port multiple ions such as Cl−/HCO3− on the basolateral surface
(Lindsey et al., 1990) or Na+/K+/Cl2− on the apical surface
(Pershing and Johanson, 1982; Plotkin et al., 1997). In addition
water channels, namely aquaporin-1, important for water transfer
across choroid plexus both in the adult and during develop-
ment, are found on the epithelial cell surfaces Nielsen et al., 1993;
Johansson et al., 2005). Plexus epithelial cells are also able to aid in
removal of compounds toxic to the nervous system. In one bizarre
case, a person with a bullet wound to the head was reported to
have a lateral ventricular choroid plexus engorged with copper
and wrapped around the bullet lodged in the ventricle (Buwembo
and DeVilliers, 1995)—with Cu2+ ion likely being transported
out of the ventricles through SLC31A1/SLC31A2 copper trans-
porters on the choroid plexus epithelium (see Saunders et al.,
2013).
It has been known for many years that solute carrier (SLC)
transporters (for review see Hediger et al., 2004; www.genenames.
org/genefamilies/SLC) are both expressed and functionally active
in the cerebral endothelial cells that comprise the blood-brain
barrier (Kusuhara and Sugiyama, 2004; Simpson et al., 2007;
Dahlin et al., 2009; Ho et al., 2012). It is now known that over
65% of the nearly 400 SLC transporters are also expressed by
epithelial cells of the choroid plexus (Saunders et al., 2013).
The main transporters defined from physiological studies are
those for glucose (GLUT-1), amino acids (acidic, basic, neutral)
monocarboxylic acids and ions, including metabolically impor-
tant ions such as Fe2+, Cu2+ and Mg+ (Bito and Myers, 1970;
Bradbury et al., 1972; Amtorp and Sørensen, 1974; Oldendorf,
1977; Cornford et al., 1982; Morgan and Moos, 2002; amongst
others). As there is such a large number of SLC transcripts, it
can prove difficult to assign these examples of more specific
molecules for which there is already a wealth of physiological
evidence of transport available. It was assumed in many early
studies focussed on entry of molecules into brain that entry
was via the blood–brain barrier interface (e.g., Oldendorf, 1977;
Cornford et al., 1982; Lefauconnier and Trouvé, 1983) and the
extent of transport of a second entry route possible via the
choroid plexuses was not fully investigated. In addition, it was
not clear from some of these reports if the CSF and choroid
plexuses had been removed prior to analysis of brain samples
- meaning any choroid plexus tissue or CSF included in brain
samples may have led to an overestimate of the contribution of
blood–brain barrier transport of the amino acids into the brain.
This contamination though small is possible to alter the out-
come of experiments as at least some amino acids are reported
to accumulate in the choroid plexuses (al-Sarraf et al., 1997a) in
addition to entering the CSF directly. Separate assessment of CSF
in the developing brain, mainly reflecting entry across choroid
plexuses, has been examined by Segal and colleagues (al-Sarraf
et al., 1997b). More recently, expression of a large number of
SLC transporters has been reported in the embryonic and adult
choroid plexus (Marques et al., 2009; Liddelow et al., 2010, 2012;
Ho et al., 2012; Saunders et al., 2013), however little physio-
logical investigation has been completed on their function or
activity.
Aquaporin-1, the main water channel in the choroid plexus,
is present in plexus epithelial cells as soon as they begin
differentiation (Johansson et al., 2005), making water transport
possible from the earliest moments in choroid plexus develop-
ment. The gradient that drives the water transport however does
not appear to be regulated in development in the same manner as
in the adult (Johansson et al., 2008a; Liddelow et al., 2013). The
two components that have proved crucial for driving an influx of
water and thus production of CSF: Na+/K+ ATPase and carbonic
anhydrase (for review see Davson and Segal, 1996; Catala, 1998;
Zheng and Chodobski, 2005), are not present in the early devel-
oping choroid plexus (Johansson et al., 2008a). An early function
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water influx may be due to the high protein concentration in the
CSF of these young animals - causing an osmotic pressure gra-
dient across the choroid plexus (see below and Johansson et al.,
2008b).
The ever complex mammalian brain contains diverse cell types
and distinct microstructures bound and protected by a number
of both physical and enzymatic/physiological brain barriers. The
large numbers of transporters present at the blood–CSF barrier
likely play crucial roles in energy metabolism, nutrient supply,
as well as CSF production and neurotransmitter regulation in
the brain, particularly during development. The now debunked
dogma that the brain develops without functional brain barriers
has been replaced with the realization that dysfunction of specific
transporter mechanisms, either genetic or acquired through some
pathological process, likely play more important roles in subse-
quent mal-development of the brain or neuropsychiatric disorder
later in life than. Thus these transporters are also potential phar-
maceutical targets for treatment of such diseases, as they are
possible targets for drug entry and toxin removal in both the
developing and adult brain.
PROTEIN
CSF in the developing brain contains characteristically high con-
centrations of plasma-derived protein when compared to the
adult. Levels for embryonic mice and rats are in the range of sev-
eral 100mg/100ml, whereas in the adult these levels fall to around
10mg/100ml (Davson and Segal, 1996), while over the same time
the level of plasma proteins circulating in the blood increases from
several 100mg/100ml to several thousand. The same trends are
consistent for rodents, marsupials and humans. The main route
of entry for this protein from plasma into CSF and brain is via
specific protein-transferring cells of the choroid plexus (Møllgård
and Saunders, 1977; Dziegielewska et al., 1980; Johansson et al.,
2006; Liddelow et al., 2009). Although the route of this transfer
has been identified as intracellular, the actual mechanism remains
unknown (Knott et al., 1997; Liddelow et al., 2009). Once pro-
teins have transferred across the choroid plexus into CSF, some
are taken up into cells in the brain, while others continue through
the ventricular system to be reabsorbed by the arachnoid gran-
ulations on the outer surface of the brain. For example some
neuroependymal cells lining the cerebral ventricles take up pro-
teins such as albumin and the fetal protein fetuin (Dziegielewska
et al., 2000). The initial cells that form the first layers of the neo-
cortex in the embryo take up fetuin via apical dendrites in contact
with the dorsal surface of the cortex (Dziegielewska et al., 2000).
Other plasma proteins such as albumin and alfa-fetoprotein are
also transported via the same route from early during develop-
ment, however, this uptake has been little studied and it is not
clear whether the proteins themselves are functionally impor-
tant or bound ligands such as hormones and growth factors are
the precious cargo. A recent publication indicated the number
of plasma protein positive cells in the ventricular zone of a fetal
mouse can be increased following an inflammatory response of
the dam—indicating protein uptake by the brain can be physio-
logically responsive to alterations in uterine environment (Stolp
et al., 2011). It is also known that this choroid plexus protein
transport system is dynamic—able to adapt to acute alterations in
levels of individual proteins circulating in the plasma (Liddelow
et al., 2014). What is not known is whether or not the choroid
plexus is able tomaintain the protein composition of the CSF after
chronic alterations in circulating proteins.
The first cells that differentiate to become choroid plexus
epithelial cells appear able to transport protein immediately,
with no apparent preference provided to cells of different stages
of development. Although there appears to be a higher degree
of specificity for individual proteins earlier in the development
(Liddelow et al., 2010), adult cells are equally able to bulk transfer
a range of proteins into the CSF without there being any trauma
or damage to the blood-CSF barrier interface. The requirement
for protein in the CSF and CNS is likely two-fold: initially the high
protein concentration reported in the CSF of early developing
animals sets up an osmotic pressure gradient causing the influx
of water and consequently improving ventricular expansion and
normal brain growth and development (Johansson et al., 2005);
and secondly, these plasma proteins are constantly attached with
large number of growth factors and other required molecules for
normal CNS maintenance—thus active transport of protein into
the CSF is a way to control import of other factors not produced
locally (Liddelow et al., 2012).
AGING AND DISEASE
The choroid plexus is unique in the CNS in that the cells, once
born and fully matured, do not undergo replacement or degen-
eration under normal conditions. In the adult, the proliferation
of choroid plexus epithelium has been shown to occur at a low
rate—less than 0.1% of total plexus cells per day (Altman and
Das, 1965; Doetsch et al., 1999; Liddelow et al., 2010), but no
data are available on the senescent plexus. There are few reports
of disease of the choroid plexus epithelium itself many cases
of plexus disability result from endothelioma of the blood ves-
sels, invading metastatic cancerous growth (accounting for less
than 0.14% of all cerebral metastases—Gopal et al., 2008), or
inflammatory lesions, however papilloma of the epithelium itself
seems to be the most common, though still only accounting for
less than 1% of all brain tumors (see Rickert and Paulus, 2000
for review). It is important to note however the high expres-
sion of Vimentin (Vim) by nearly all choroid plexus tumors
suggests a vascular cell abnormality, while the presence of the
astrocytic marker glial fibrilliary acidic protein (Gfap) in up to
50% of plexus neoplasms suggests some conversion of epithe-
lial cells to glial lineages (Rickert and Paulus, 2000), as has been
reported for plexus implantation in spinal cord (Ide et al., 2001;
Kitada et al., 2001). Other reports in multiple sclerosis describe
HLA-DR (a MHC class II cell surface receptor encoded by the
human leukocyte antigen) composites on choroid plexus epithe-
lial cells (Vercellino et al., 2008), however closer inspection of the
micrographs suggest these deposits are actually present in epi-
plexus cells as they are never central to the epithelial cell and
always contain a separate nucleus. It seems that regardless of
case-study age, race, or location, these diseases of the choroid
plexus are rare, and to date no study descriptions or animal
models are able to accurately describe insufficiencies in normal
plexus function (although anencephalic expansion due to excess
CSF production by the choroid plexuses is widely reported).
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Rarer still are descriptions of changes in the choroid plexus dur-
ing normal aging. The choroid plexus performs continuous and
vital function, producing up to 75–90% (approximately 450–
1000ml/day) of the CSF (see Davson and Segal, 1996). This
fluid adequately nourishes the brain prior to full vasculariza-
tion (see above) and provides buoyant suspension and protection
to the brain and spinal cord. During normal aging there have
been reports of filamentous, ring-like or arc-like structures in
the epithelium of the choroid plexus, termed Biondi bodies
(Biondi, 1933; Oksche and Kirschstein, 1972; Kiktenko, 1986;
Wen et al., 1999; see also Figure 4). Structurally these filamentous
rings are associated with lipid droplets, and appear to develop
within the epithelial cells themselves (and thus may be agents
of cellular destruction) rather than in the extracellular matrix,
however the study by Kiktenko (1986) makes special mention of
the fact they were unable to find convincing signs of damage in
plexus epithelial cells with large-sized Biondi bodies. Inspection
of the electron micrographs however clearly shows examples of
these tangled rings bursting forth from ruptured plexus epithe-
lial cells, while nearby ring-free cells are noticeably undamaged
(see Figure 4B). These Biondi bodies, or Biondi ring tangles, are
not seen between adjacent cells - only in the cytoplasm of plexus
epithelia. This intracellular location of the Biondi bodies and
their state of preservation compared to other cytoplasmic ele-
ments suggest a destructive effect on epithelial cells of choroid
plexuses. The more common occurrence in Alzheimer’s disease
(Miklossy et al., 1998) suggests dementia disease states may cause
premature aging of the choroid plexus, as epithelial atrophy is sig-
nificantly accentuated (as reported by a decrease in cell height is
observed compared to age-matched controls (Serot et al., 2000).
Choroid epithelial cells also acquire numerous other lipofus-
cin vacuoles (along with Biondi bodies) in Alzheimer’s patients
(Miklossy et al., 1998; Wen et al., 1999; Alvira-Botero and Carro,
2010). These Biondi inclusions have thus far proved difficult
to image extensively, as the presence only in higher-order pri-
mates and humans presents issues for both tissue availability and
preservation. The light and transmission electron micrographs
provided byWen et al. (1999; see Figures 4A,C) come frommate-
rial obtained from tissue banks and as such no information is
provided on tissue preparation protocols. Older material pre-
pared for scanning electron microscopy by Kiktenko (1986; see
Figure 4B) was prepared from a wide range of aged and otherwise
healthy human autopsies that were fixed within 1.5–4.5 h after
death. In these images it is possible to see choroid plexus epithelial
cells bursting, possibly due to Biondi ring inclusions and not an
artifact of fixation as all burst cells contain these ring structures.
Whatever their effect on the plexus, it is true to say that Biondi
bodies are characteristic of choroidal epithelia of aged humans.
Their absence in young-to-middle aged non-human primates,
as well as their absence in various senescent mammals (rodents,
dogs, and cats) and birds, has led to suggestions they may relate
to differences in brain senescence between humans and other ani-
mals. However, Biondi-like inclusions have been identified in an
aged (43 year old) male chimpanzee (Oksche et al., 1984).
The choroid plexus therefore demonstrates a robust accumu-
lation of pathological changes, in the form of Biondi bodies,
with normal aging, however the changes to normal function are
FIGURE 4 | Biondi ring tangles in aged human choroid plexus of the
lateral and fourth choroid plexus. (A) Fluorescent light micrograph of
thioflavin S-stained Biondi ring tangles (arrows) in the choroid plexus of the
brain of a 78-year-old human female with Alzheimer’s disease showing
Biondi ring tangles appear as ring, tangle, serpentine, and curled profiles.
(Magnification: 530×). (B) Scanning electron micrograph (Magnification
2500 ×) showing destruction of plexus epithelial cell containing ring-like
Biondi inclusions. Arrow marks a ring bursting from an individual plexus
epithelial cell. Material from 78 year old woman. (C) Electron micrograph of
a choroid plexus from a 70-year-old male with Alzheimer’s disease showing
the fibrous Biondi ring tangles (one highlighted in pink, the other in green)
associated with lipofuscin granules, mitochondria, and other cellular
components. (Magnification: 10,300×). (A,C) Reproduced from Wen et al.,
1999 Copyright ©1999 Elsevier Science B.V. All rights reserved. (B)
Reproduced from (Kiktenko, 1986) Copyright ©1986 Springer All rights
reserved. Abbreviations: BV, blood vessel; CPEC, choroid plexus epithelial
cell; CSF, cerebrospinal fluid; N, nucleus.
difficult to ascertain, as no rodent examples are reported thus
study of their effects cannot be completed. It is likely however
these modifications could alter choroid plexus function, includ-
ing synthesis, secretion, and transport of proteins and other
molecules. A possible reason for this amazing cellular longevity
is the high expression of the aging repressor Klotho (Kl, see
Liddelow et al., 2012). KLOTHO protein is a serum circulating
factor that declines with age (Kuro-o et al., 1997; Xiao et al., 2004).
Mice deficient for KLOTHO protein manifest a syndrome simi-
lar to accelerated human aging and display rapid and extensive
arteriosclerosis. Although the vast majority of research has been
based on lack of KLOTHO, it is demonstrated an overexpression
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of Kl transcript in mice extends their average life span between
19 and 31% compared to normal mice (Kurosu et al., 2005). The
high expression of Kl throughout plexus development and into
the adult suggests some protective effect on plexus epithelial cells
themselves, and also on other CNS cells— especially considering
evidence that KLOTHO protein levels in the CSF are decreased in
Alzheimer’s disease humans (Semba et al., 2014).
To date, the only study of the choroid plexus in systemic dis-
ease has been reported by Dohrmann and Herdson (1969). They
used NZB/NZW hybrid mice, a strain which develops a disease
resembling human systemic lupus erythematosus. Fine structural
examination of the choroid plexus revealed an irregular, homo-
geneous thickening of the capillary basement membranes. Other
miscellaneous reports on the pathology of the choroid plexus
include Hoff (1930), Rand and Courville (1931) and Leviton et al.
(1977). Hoff (1930) reported on increased permeability of the
choroid plexus in experimental head injury. Another survey of
62 cases of fatal cerebral trauma noted oedema of the stroma and
vacuolation of the epithelial cells of the choroid plexus (Rand and
Courville, 1931). The presence of amyloid in the choroid plexus of
elderly brains was described by Divry (in Blackwood et al., 1963).
Amyloid was present within the choroidal epithelium, confined
to the free margins of the cells.
CONCLUDING REMARKS
On February 7th 1922, Sir John Bland-Sutton gave what was by
all accounts an energetic emeritus lecture at Middlesex Hospital,
Enland, entitled “The choroid plexus and psammomas.” As an
introduction to the choroid plexus he commented “The ruffle-
like structures, called choroid plexuses, which float in the ventric-
ular fluid of man’s brain, have aroused the curiosity of anatomists
for centuries, yet they took little more interest in them than
gardeners take in weeds.” Though we have moved on from hum-
ble gardeners, until recently the neuroscience community has
lagged in the uptake of important studies focussed on the choroid
plexus. As a structure that produces and secretes CSF, controls
and protects the internal environment of the adult CNS, and is
present even before vascularization of other cortical structures,
surely we have sufficient evidence to justify serious investigations
into this small epithelial tissue mass in the ventricles of all ver-
tebrates. This review has touched on the early development of
the choroid plexuses, and its emergence as a possible location
of serious complications in aging and disease. Indeed the close
homeostatic control of the internal milieu of the CNS: the CSF,
glia, and neurons, plays a vital role in normal and abnormal brain
function. Dysfunctions of all of the brain barriers contribute
heavily to the pathology of neurological conditions, however the
added detriment of a dysfunctional choroid plexus during devel-
opment is additional reason for concern. A proper understanding
of the choroid plexus will likely prove important for the produc-
tion of drug delivery and therapies to help ameliorate a wide range
of neurological diseases.
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